Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven), By End-use (Hospitals, Clinics), By Application (Oncology), By Region, And Segment Forecasts, 2024 - 2030

Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven), By End-use (Hospitals, Clinics), By Application (Oncology), By Region, And Segment Forecasts, 2024 - 2030


Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 23.89 billion by 2030, expanding at a CAGR of 18.11 from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring.

Technological advancements in wearable injectors, for instance, Bluetooth integrated wearable injectors, send alerts to patients, such as injection reminders and data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and some devices prevent accidental activation. They also have audible and visual status indicators or signals. Patients can self-administer drugs subcutaneously with minimal time and effort as compared to intravenous or other routes. Patients don’t need to visit any healthcare provider for the administration.

The prevalence of lifestyle-associated diseases, such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. The advanced ecosystem of these devices helps healthcare care providers to access data from remote location, which reduces clinical decision time. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access to data with reduced errors, is expected to boost the wearable injectors market.

Wearable Injectors Market Report Highlights
  • The on-body wearable injectors accounted for the largest revenue share in 2023 owing to the growing preference of the patients for adhesive patches that release the drug conveniently and can be worn on the skin
  • The motor-driven segment is expected to register the highest growth during the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies
  • The oncology segment is expected to hold the largest market share due to the globally increasing incidences of cancer
  • The home care segment is expected to dominate the market with the highest market share owing to increasing inclination towards the home-based treatments onset of Covid-19 pandemic can be seen and it has positively impacted the home care segment growth
  • North America accounted for the largest revenue share of 33.2% in 2023. It is attributed to the rising prevalence of chronic & lifestyle-related diseases and augmented healthcare infrastructure.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Technology
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Wearable Injectors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Wearable Injectors Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Wearable Injectors Market: Type Estimates & Trend Analysis
4.1. Wearable Injectors Market: Key Takeaways
4.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
4.3. On-body
4.3.1. On-body market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Off-body
4.4.1. Off-body market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Wearable Injectors Market: Technology Estimates & Trend Analysis
5.1. Wearable Injectors Market: Key Takeaways
5.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
5.3. Spring-based
5.3.1. Spring-based market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Motor-driven
5.4.1. Motor-driven market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Rotary Pump
5.5.1. Rotary pump market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Expanding Battery
5.6.1. Expanding battery market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Wearable Injectors Market: Application Estimates & Trend Analysis
6.1. Wearable Injectors Market: Key Takeaways
6.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
6.3. Oncology
6.3.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Infectious Disease
6.4.1. Infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Cardiovascular Disease
6.5.1. Cardiovascular disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Autoimmune Disease
6.6.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Immunodeficiency
6.7.1. Immunodeficiency market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Wearable Injectors Market: End-use Estimates & Trend Analysis
7.1. Wearable Injectors Market: Key Takeaways
7.2. Wearable Injectors Market: Movement & Market Share Analysis, 2023 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Clinics
7.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Home Care
7.5.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Wearable Injectors Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Wearable Injectors Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Key country dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory framework
8.3.2.4. Reimbursement scenario
8.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
8.3.3. Canada
8.3.3.1. Key country dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory framework
8.3.3.4. Reimbursement scenario
8.3.3.5. Canada market estimates and forecasts, 2018 - 2030
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Competitive Scenario
8.4.1.3. Regulatory framework
8.4.1.4. Reimbursement scenario
8.4.1.5. UK market estimates and forecasts, 2018 - 2030
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory framework
8.4.2.4. Reimbursement scenario
8.4.2.5. Germany market estimates and forecasts, 2018 - 2030
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory framework
8.4.3.4. Reimbursement scenario
8.4.3.5. France market estimates and forecasts, 2018 - 2030
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory framework
8.4.4.4. Reimbursement scenario
8.4.4.5. Italy market estimates and forecasts, 2018 - 2030
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory framework
8.4.5.4. Reimbursement scenario
8.4.5.5. Spain market estimates and forecasts, 2018 - 2030
8.4.6. Denmark
8.4.6.1. Key country dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory framework
8.4.6.4. Reimbursement scenario
8.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory framework
8.4.7.4. Reimbursement scenario
8.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
8.4.8. Norway
8.4.8.1. Key country dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory framework
8.4.8.4. Reimbursement scenario
8.4.8.5. Norway market estimates and forecasts, 2018 - 2030
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Competitive Scenario
8.5.1.3. Regulatory framework
8.5.1.4. Reimbursement scenario
8.5.1.5. Japan market estimates and forecasts, 2018 - 2030
8.5.2. India
8.5.2.1. Key country dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. India market estimates and forecasts, 2018 - 2030
8.5.3. China
8.5.3.1. Key country dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement scenario
8.5.3.5. China market estimates and forecasts, 2018 - 2030
8.5.4. South Korea
8.5.4.1. Key country dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory framework
8.5.4.4. Reimbursement scenario
8.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
8.5.5. Australia
8.5.5.1. Key country dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory framework
8.5.5.4. Reimbursement scenario
8.5.5.5. Australia market estimates and forecasts, 2018 - 2030
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory framework
8.5.6.4. Reimbursement scenario
8.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory framework
8.6.1.4. Reimbursement scenario
8.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
8.6.2. Mexico
8.6.2.1. Key country dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. Mexico market estimates and forecasts, 2018 - 2030
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. Argentina market estimates and forecasts, 2018 - 2030
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory framework
8.7.1.4. Reimbursement scenario
8.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory framework
8.7.3.4. Reimbursement scenario
8.7.3.5. UAE market estimates and forecasts, 2018 - 2030
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory framework
8.7.4.4. Reimbursement scenario
8.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 9. Competitive Landscape
9.1. BD
9.2. Johnson & Johnson Services, Inc.
9.3. F. Hoffmann-La Roche Ltd.
9.4. Unilife Corporation
9.5. Steady Med Therapeutics, Inc.
9.6. Amgen Inc.
9.7. Insulet Corporation
9.8. Enable Injections
9.9. West Pharmaceutical Services, Inc.
9.10. CeQur Simplicity

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings